Meng MV - Search Results

1

Integrative analysis of the epigenetic basis of muscle-invasive urothelial carcinoma.

Sanford T, Meng MV, Railkar R, Agarwal PK, Porten SP. Sanford T, et al. Among authors: meng mv. Clin Epigenetics. 2018 Feb 12;10:19. doi: 10.1186/s13148-018-0451-x. eCollection 2018. Clin Epigenetics. 2018. PMID: 29456764 Free PMC article.

2

Endoscopic and minimally invasive approaches to upper tract urothelial carcinoma.

Park S, Meng MV. Park S, et al. Among authors: meng mv. Curr Opin Urol. 2005 Sep;15(5):336-41. doi: 10.1097/01.mou.0000173283.72377.29. Curr Opin Urol. 2005. PMID: 16093859 Review.

3

Outcomes of active surveillance for men with intermediate-risk prostate cancer.

Cooperberg MR, Cowan JE, Hilton JF, Reese AC, Zaid HB, Porten SP, Shinohara K, Meng MV, Greene KL, Carroll PR. Cooperberg MR, et al. Among authors: meng mv. J Clin Oncol. 2011 Jan 10;29(2):228-34. doi: 10.1200/JCO.2010.31.4252. Epub 2010 Nov 29. J Clin Oncol. 2011. PMID: 21115873 Free PMC article.

4

The relationship between prostate specific antigen change and biopsy progression in patients on active surveillance for prostate cancer.

Whitson JM, Porten SP, Hilton JF, Cowan JE, Perez N, Cooperberg MR, Greene KL, Meng MV, Simko JP, Shinohara K, Carroll PR. Whitson JM, et al. Among authors: meng mv. J Urol. 2011 May;185(5):1656-60. doi: 10.1016/j.juro.2010.12.042. Epub 2011 Mar 21. J Urol. 2011. PMID: 21419438 Free article.

5

Changes in prostate cancer grade on serial biopsy in men undergoing active surveillance.

Porten SP, Whitson JM, Cowan JE, Cooperberg MR, Shinohara K, Perez N, Greene KL, Meng MV, Carroll PR. Porten SP, et al. Among authors: meng mv. J Clin Oncol. 2011 Jul 10;29(20):2795-800. doi: 10.1200/JCO.2010.33.0134. Epub 2011 May 31. J Clin Oncol. 2011. PMID: 21632511 Free article.

6

The role of active surveillance in the management of prostate cancer.

Fung-Kee-Fung SD, Porten SP, Meng MV, Kuettel M. Fung-Kee-Fung SD, et al. Among authors: meng mv. J Natl Compr Canc Netw. 2013 Feb 1;11(2):183-7. doi: 10.6004/jnccn.2013.0026. J Natl Compr Canc Netw. 2013. PMID: 23411385

7

Molecular Analysis of Upper Tract and Bladder Urothelial Carcinoma: Results from a Microarray Comparison.

Sanford T, Porten S, Meng MV. Sanford T, et al. Among authors: meng mv. PLoS One. 2015 Aug 28;10(8):e0137141. doi: 10.1371/journal.pone.0137141. eCollection 2015. PLoS One. 2015. PMID: 26317352 Free PMC article.

8

The Cancer of the Bladder Risk Assessment (COBRA) score: Estimating mortality after radical cystectomy.

Welty CJ, Sanford TH, Wright JL, Carroll PR, Cooperberg MR, Meng MV, Porten SP. Welty CJ, et al. Among authors: meng mv. Cancer. 2017 Dec 1;123(23):4574-4582. doi: 10.1002/cncr.30918. Epub 2017 Sep 7. Cancer. 2017. PMID: 28881475 Free article.

9

Determinants of Guideline-Based Treatment in Patients With cT1 Bladder Cancer.

Balakrishnan AS, Washington SL 3rd, Meng MV, Porten SP. Balakrishnan AS, et al. Among authors: meng mv. Clin Genitourin Cancer. 2019 Jun;17(3):e461-e471. doi: 10.1016/j.clgc.2019.01.007. Epub 2019 Jan 19. Clin Genitourin Cancer. 2019. PMID: 30799130

10

Social Determinants of Appropriate Treatment for Muscle-Invasive Bladder Cancer.

Washington SL 3rd, Neuhaus J, Meng MV, Porten SP. Washington SL 3rd, et al. Among authors: meng mv. Cancer Epidemiol Biomarkers Prev. 2019 Aug;28(8):1339-1344. doi: 10.1158/1055-9965.EPI-18-1280. Epub 2019 May 15. Cancer Epidemiol Biomarkers Prev. 2019. PMID: 31092404 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

207 results

Search Page

Filters